Detalhe da pesquisa
1.
Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION study.
Ann Allergy Asthma Immunol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697286
2.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Lancet Respir Med
; 11(5): 425-438, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702146
3.
Properties of Langmuir and solid supported lipid films with sphingomyelin.
Adv Colloid Interface Sci
; 222: 385-97, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24725646